Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

4basebio

Tracked across 3 events · 19 articles · First seen May 20, 2026 · Last active Aug 26, 2026

Sentiment
53
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Business
Impact: 4basebio signed a Clinical Supply Agreement to provide GMP-grade opDNA for a Phase II clinical trial, securing a seven-figure revenue stream and demonstrating the commercial momentum of its technology.
May 20, 2026 · 6 articles
2 50
Business
Impact: 4basebio appointed Jeff Coller to its Strategic Advisory Board, which is expected to enhance its synthetic DNA and mRNA manufacturing capabilities and strategic direction.
Jun 15, 2026 · 6 articles
2 40
Business
Impact: 4basebio is the primary beneficiary, as the collaboration expands market access for its hpDNA technology, potentially driving revenue growth and validating its platform.
Aug 26, 2026 · 7 articles
ERGEN INTELLIGENCE
Track 4basebio live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.